Type Public Industry Pharmaceuticals Founded 1997 | Traded as NASDAQ: GTXI Website GTxInc.com | |
 | ||
Products Toremifene, Ostarine, Andarine Stock price GTXI (NASDAQ) US$ 5.26 +0.46 (+9.58%)8 Mar, 4:00 PM GMT-5 - Disclaimer Headquarters Memphis, Tennessee, United States | ||
GTx, Inc is a pharmaceutical company and developer of drugs that utilize hormonal pathways. Its major product to date is toremifene, and drugs in development include enobosarm (ostarine) and GTx-758. The company has undertaken partnerships with other biotechnology companies such as Merck in the development of drugs in the selective estrogen receptor modulator (SERM) and selective androgen receptor modulator (SARM) classes.
References
GTx Incorporated Wikipedia(Text) CC BY-SA